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Chapter 2
Translational control in endothelial cells
Peter B. Brant-Zawadzki, MD,a Douglas I. Schmid, MD,b Huimao Jiang, MD,b
Andrew S. Weyrich, MD,b,c Guy A. Zimmerman, MD,b,c and Larry W. Kraiss, MD,a,b Salt Lake City, Utah
Cellular phenotype and function is ultimately determined by the synthesis of proteins derived from a genetic blueprint.
Control of gene expression occurs at multiple checkpoints, including the transcription of DNA into RNA and the
translation of RNA into protein. Translational control mechanisms are important regulators of cellular phenotype,
controlling up to 10% of overall cellular gene expression, yet they remain relatively understudied when compared with
transcriptional control mechanisms. Specific regulation of protein synthesis from messenger RNA transcripts allows cells
to temporally unlink translation from transcription and provides a mechanism for a more rapid response to environmen-
tal signals than if transcription were required. We discuss some of the fundamental concepts of translational control, tools
for studying it and its relevance to vascular cells, in particular the endothelium. (J Vasc Surg 2007;45:8A-14A.)The central dogma of molecular biology states that
genetic information flows from DNA to messenger RNA
(mRNA; transcription), and frommRNA to protein (trans-
lation).1 This model illustrates that genomic DNA does not
direct protein synthesis itself, but instead uses mRNA as an
intermediary molecule. It is the synthesis of protein from
these intermediary mRNA transcripts that ultimately deter-
mines cellular phenotype and function. Despite this fact,
there is relatively little research into the specific regulation
of protein synthesis (as opposed to transcription) in vascu-
lar cells.2
The classic view of gene expression describes a series of
events triggered by some type of signal that stimulates a cell
to transcribe its genetic blueprint, or DNA, into RNA. This
transcript is then processed and transported out of the
nucleus and into the cytoplasm. Next, the RNA is trans-
lated into protein by ribosomes, yielding a protein that
ultimately changes the cell’s structure or function to adapt
to the initial signal (Fig 1). This simplistic, assembly line
view of gene expression suggests that genes are either “on”
or “off” as opposed to modulated. Another shortcoming of
this model is that it espouses an obligatory temporal rela-
tionship in which transcription begets translation rather
than a scenario in which many regulatory factors may
independently (or perhaps simultaneously) work at multi-
ple checkpoints during gene expression.
Clearly, transcription is an essential process: translation
cannot occur in the absence of mRNA. Transcription is also
the most common site of regulated gene expression, being
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8Atargeted up to 90% of the time when a cell responds to a
stimulus.1 Transcription is time-consuming, however, and
requires a significant amount of energy. Translational con-
trol is an important means of regulating gene expression
because it offers an additional level of control in determin-
ing which genes are ultimately expressed in protein form,
when, and how much, and because it can occur temporally
independent of transcription. There are important in-
stances in which it is to the cell’s advantage to dissociate
transcription from translation; this review focuses on some
of those instances.
TRANSLATIONAL CONTROL DEFINED AND
ITS ADVANTAGES
Translational control is defined as a change in the
efficiency or rate of protein translation of one or more
mRNAs resulting in a change in the number of synthesized
proteins over time. The benefits of controlling gene expres-
sion at the level of translation may be summed up in terms
of immediacy, precision, and redundancy.3
Immediacy is self-explanatory: if a cell needs to rapidly
change its function or phenotype in response to some
stimulus, it is much faster to change the translation rate of
pre-existing mRNA than it is to synthesize new mRNA
before being able to translate proteins from that transcript.
Many cells synthesize mRNA and then store it for future
use without immediately translating it.4 These mRNA tran-
scripts are then available for rapid mobilization to the
translational apparatus and a rapid change in protein ex-
pression given the appropriate stimulus. Such instances are
the most obvious example of temporal dissociation of tran-
scription and translation.
Translational control offers increased precision of gene
expression by regulating small changes in overall protein
levels towards the end of a long, complex pathway rather
than at the beginning. Take an automotive assembly line,
for example. The end product is a car (protein) resulting
from a manufacturing process using various raw materials
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output of the assembly line needs to change by 10%, it
makes more sense to exert that control at some point
during the assembly process rather than by changing the
overall availability of raw materials at the front end.
The combination of transcriptional and translational
control (redundancy) helps to avoid dysregulated expres-
sion of potentially harmful molecules. This is analogous to
multiple back-up systems in spacecraft and commercial
airlines in which catastrophic malfunctions supposedly can-
not occur as a result of a single system failure. Translational
control is often imposed on critical gene products such as
oncogenes, growth factors, and signaling molecules.5
It is useful to distinguish between global and selective
translational control. Global controls govern general pro-
cesses necessary to translate mRNA and therefore affect
translational rates of all classes of mRNA transcripts. Global
controls are sensitive to the availability of “raw materials”
such as amino acids or energy substrates and are responsible
for the overall decrease in protein synthesis that occurs
during starvation. Selective controls target features unique
to a given mRNA molecule or class of mRNAs possessing
that feature. Therefore, a unique subset of mRNA tran-
scripts can be translationally repressed despite an abun-
dance of activated translational components (such as ribo-
somes), or specialized mRNA transcripts may be increasingly
translated despite a condition in which overall protein
synthesis is reduced (such as heat shock).6
TRANSLATIONAL CONTROL MACHINERY AT
THE MOLECULAR LEVEL
Synthesizing protein from mRNA transcripts in-
volves three basic steps: (1) initiation, the recruitment
and assembly of intact ribosomes at a start codon; (2)
elongation, the sequential addition of amino acid residues;
and (3) termination, the dissociation of intact ribosomes
from the mRNA transcript. In eukaryotic cells, the initia-
tion of translation is a highly regulated, complex process
Fig 1. An illustration of the classic view of gene regulation, in
which an extracellular signal triggers a sequential series of tempo-
rally related events leading from DNA to messenger RNA
(mRNA) to protein.that is the rate-limiting step where regulation of translationmost commonly occurs. Translational control is seldom
exerted at the elongation or termination steps and is not
further described.
The molecular machinery required for initiation in-
cludes an appropriately processed mRNA molecule, ribo-
somes, transfer RNA (tRNA) molecules with their associ-
ated amino acids, and a group of additional proteins known
as eukaryotic initiation factors or eIFs.3 After RNA is tran-
scribed fromDNA in the nucleus, it is processed by capping
the 5=-end with a methylated guanosine, splicing out non-
coding intronic sequences, and polyadenylation at the 3=-
tail (Fig 2). This mature mRNA transcript is then exported
into the cytoplasm where translation occurs.
The initiation of translation can occur in several differ-
ent ways, but the scanning model is thought to be the most
common.3 In this model, the 40S subunit of a ribosome
binds to the capped 5=-terminus of a mature mRNA with
the assistance of multiple eIFs (Fig 2). This mode of initi-
ation is thus termed cap-dependent translation.
Immediately downstream of the 5=-cap is a section of
the mRNA transcript known as the 5= untranslated region
(UTR), which must be scanned by the 40S ribosome
subunit before reaching the start codon. The length and
secondary structure of the 5=-UTR can profoundly influ-
ence translational efficiency by altering access of eIFs to the
5=-cap or by preventing smooth scanning to the start
codon.3 Messenger RNA transcripts that possess 5=-UTR
sequences with an extensive secondary structure frequently
code for oncoproteins, growth factors, transcription fac-
tors, and proteins that must be tightly regulated for normal
cellular function and are an illustration of redundancy.5
There are multiple opportunities for specific control
Fig 2. The traditional scanningmodel illustrates the cap-dependent
initiation of translation in which eukaryotic initiation factors facil-
itate ribosome binding to the capped 5=-end of a messenger RNA
(mRNA) transcript. Cap-independent translation is also depicted,
in which an internal ribosome entry site (IRES) with a complex
secondary structure facilitates ribosome binding in the 5= untrans-
lated region (UTR).events to occur during the initiation process. Various signal
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40S ribosome subunit and eIFs can attach and begin scan-
ning. Additional signal inputs may be necessary to assist
scanning through highly structured and complicated 5=-
UTRs andmay involve regulated association or dissociation
of various RNA-binding proteins with particular motifs in
this region. Translational control can also be exerted
through specific interactions between the RNA-binding
proteins with the 3=-UTR but are not further discussed
here. The types of control that involve regulation of specific
events at the mRNA UTRs tend to be selective rather than
global.
Once the start codon (AUG) is recognized, the bound
eIFs are released from the 40S subunit to allow binding of
the 60S ribosomal subunit.7,8 A separate eIF is necessary to
catalyze the formation of a complete 80S ribosome from
the two subunits. At this point, the ribosome is fully
assembled on the mRNA transcript at the start codon
and translation begins as tRNA molecules supply the
appropriate amino acids for protein synthesis. As the
ribosome progresses along the transcript, the polypeptide
product elongates until the ribosome complex reaches the
stop codon towards the end of the 3=-terminus, and trans-
lation ceases.9
Another model for eukaryotic protein synthesis is based
upon the concept of cap-independent translation. This
model does not rely on the 5=-mRNA cap with its associ-
ated eIFs to recruit ribosomes, as does the scanning model.
Instead, internal ribosome entry sites (IRES) exist in which
a ribosome can bypass binding to the capped 5=-end of an
mRNA and attach directly at a site downstream, within the
5=-UTR (Fig 2).3
Viral genomes provided the first evidence for IRES
elements because their RNA is not processed and capped as
it is in eukaryotes.10 Furthermore, many viruses actually
inhibit the host cell’s normal process of cap-dependent
translation by disabling key eIFs necessary for cap recogni-
tion.11 Viral protein synthesis typically occurs because the
host cell ribosomes are diverted from cap-dependent trans-
lation of host cell mRNA to cap-independent translation of
viral mRNA. It is now appreciated that there are multiple
mechanisms for ribosomal recruitment to IRES elements,
and there is a growing body of evidence that cells may use
cap-independent translation for host protein synthesis at
specific times: cellular differentiation,12 apoptosis,13 and
in certain pathologic conditions such as Charcot-Marie-
Tooth disease and multiple myeloma.14-16
TECHNIQUES FOR STUDYING
TRANSLATIONAL CONTROL
Regardless of the manner in which translation is initi-
ated, the ribosome is a fundamental component required
for protein synthesis. A single, functional ribosome physi-
cally occupies only a short stretch of mRNA, allowing
multiple ribosomes to attach to the same transcript to more
efficiently produce the protein being synthesized. Tran-
scripts with multiple ribosomes attached are termed polyri-bosomes, or polysomes, and transcripts associated with a
solitary ribosome are termed monosomes.
Recall that the formal definition of translational control
involves a change in the efficiency of mRNA translation or
a change in the number of completed proteins per unit of
time. Direct measurement of this parameter is very difficult,
so a more convenient surrogate measure is typically used to
indirectly assess translational efficiency. This surrogate
measurement is the number of ribosomes attached to a
given mRNA transcript. Because initiation is usually the
rate-limiting step in translation, the number of ribosomes
attached to a given mRNA molecule also reflects the effi-
ciency of initiation, which is also the most common site of
control. Thus, measurement of the number of ribosomes
attached to various mRNA molecules under various condi-
tions provides important clues to the regulatory events
governing translation in those particular situations. Specif-
ically, mRNA transcripts associated with polysomes are
presumed to be efficiently translated, whereas mRNA tran-
scripts associated with monosomes (or not present in the
ribosomal preparation at all) are inefficiently translated.
The technique of ribosome profiling (Fig 3) is used to
assess how many ribosomes are attached to mRNA mole-
cules.
The most important concept in the experimental study
Fig 3. Ribosome profiling. A, Efficiently translated messenger
RNA (mRNA) transcripts (polysomes) are separated from ineffi-
ciently translated mRNA transcripts (monosomes) by using su-
crose density gradient centrifugation. Because individual ribo-
somes are so heavy, discrete bands are produced that correspond to
an integer number of ribosomes in a polysome. After centrifuga-
tion, the gradients are passed through a spectrophotometer that
generates tracings based on the presence of genetic material to
facilitate separation of the monosome fraction from the polysome
fraction. B, In general, conditions characterized by high transla-
tional activity (such as cell growth or proliferation) will have
mRNA predominantly associated with polysomes (dashed line),
and conditions characterized by low translational activity (such as
starvation) will have mRNA predominantly associated with mono-
somes (solid line).of translational regulation is the idea that signal-dependent
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the polysome or monosome fractions is prima facie evi-
dence of translational control. A widely used parameter to
reflect translational efficiency for a given mRNA is the
“translation state,” which is simply the ratio of the amount
of mRNA in the polysome fraction divided by the amount
of mRNA in the monosome fraction. Messenger RNA
species with translation state 1 are efficiently translated
and those with a translation state 1 are not. A significant
change in measured translation state between different
experimental conditions is also evidence of translational
control.
Initially, methods for direct analysis of protein expres-
sion (or proteome analysis) were cumbersome, insensitive,
and limited in their ability to assess large numbers of genes
for translational activity.17 Classically, translational control
was recognized in experiments when a given condition
could induce changes in protein levels without correspond-
ing changes in mRNA levels.
A high-throughput method for simultaneously moni-
toring the translational state of large numbers of individual
mRNA species was first described in 1999 by Zong et al.18
This technique, known as translation state array analysis
(TSAA; Fig 4), combines microarray technology with ribo-
somal profiling to determine the translation state of thou-
sands of mRNA species simultaneously.
Poorly translated mRNA transcripts associated with
monosomes are separated from efficiently translated mRNA
transcripts in polysomes by ribosomal profiling (Fig 3). I n this
instance, all fractions containing two ormore ribosomes are
pooled to form the polysome fraction. After isolation of
RNA from monosome or polysome fractions, fluorescent-
labeled complimentary DNA (cDNA) copies of the mRNA
transcripts are synthesized and used to interrogate DNA
arrays on which thousands of known gene sequences are
bound. Because monosome cDNA is labeled with a differ-
ent fluorophore than polysome cDNA, competitive hybrid-
ization yields a measure of the translation state for each
gene on the array (Fig 4).
If separate arrays are used for control and test condi-
tions, the simultaneous measurement of experimentally
induced changes in translation state for thousands of genes
is possible. The change in translation state for a given
experiment can be expressed by the translation index,
which is simply the ratio of the measured translation state
under the experimental conditions divided by themeasured
control translation state. A translation index 1 implies
translational upregulation since the conditions of the ex-
periment have redistributed mRNA to the polysome rela-
tive to the control situation. A translation index1 implies
translational repression since the experiment has resulted in
a redistribution of mRNA out of the polysome and into the
monosome. A key attribute of TSAA is that it can recognize
translational control even when there is concomitant tran-
scriptional control, because the translation state and the
translation index only reflect the proportions (not total
amounts) of mRNA in the two fractions.If a third array chip is added to a given experiment,
transcriptional control can also be directly assessed by tra-
ditional microarray methods. Total RNA is isolated from
cells in both the treatment and control conditions and
fluorescently labeled cDNA probes from both conditions
are used to competitively hybridize with the third chip.
Thus, with three arrays, it is possible to simultaneously
assess both transcriptional and translational changes. Based
on the results of TSAA experiments, we have categorized
nine different patterns in which gene expression is poten-
tially regulated in response to a given stimulus in terms of
transcriptional and translational indices (Table).
Data derived from TSAA experiments should be vali-
dated using molecular biology techniques such as quanti-
tative polymerase chain reaction (PCR). In addition,
Fig 4. Translation state array analysis (TSAA). This high-
throughput method for assessing the translation state (TS) of a
large number of messenger RNAs (mRNAs) combines ribosomal
profiling and microarray technology. Cellular mRNAs are sepa-
rated into inefficiently translated fractions (monosomes) or effi-
ciently translated fractions (polysomes). The mRNAs are then
converted into complementary DNA (cDNA) labeled with a fluo-
rescent marker (Cy3 is green and Cy5 is red) and hybridized to an
array chip containing thousands of genes. If there is a larger
amount of mRNA for a certain gene sequence in the monosome
fraction, that spot on the chip (representing that gene) will fluo-
resce green and will have a corresponding TS 1, where TS
represents the mRNA in the polysome fraction divided by the
mRNA in the monosome fraction. If there is a larger amount of
mRNA for a certain gene sequence in the polysome fraction, that
spot on the chip will fluoresce red and will have a corresponding
TS 1. If there are equivalent amounts of mRNA for both the
monosome and polysome fractions, then that spot will fluoresce
yellow and have a corresponding TS  1. If there is no hybridiza-
tion of the probes to the gene in question, the spot will not
fluoresce. Once the translational states are determined for each
gene on the control array, they can be compared with the transla-
tional states for each gene on the experimental array. A ratio of the
TS for each gene under experimental conditions divided by the TS
for control conditions will yield a translational index. This value
represents the redistribution of mRNA between monosome and
polysome fractions for the given experimental condition.TSAA-derived data do not give any information about the
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biologic studies are still necessary to determine the impor-
tance of the observed changes in translation (and transcrip-
tion).
TRANSLATIONAL CONTROL IN
VASCULAR CELLS
Vascular endothelial cells prominently use translational
control mechanisms. Despite early beliefs that these cells
were merely bystanders lining the inside of the blood
vessels, it is now clear that they play a dynamic role in
determining the ultimate biologic behavior of the vessel
wall.19 Endothelial cells respond to signals from the envi-
ronment with rapid functional and phenotypic changes.
These alterations in endothelial phenotype are inducible by
a variety of agonists that act at various receptors. Unreg-
ulated endothelial activation is found in numerous
pathologic conditions, including sepsis, inflammation,
and ischemia-reperfusion injury.20 With the explosion of
endovascular interventions, there is also an increasing
amount of direct mechanical trauma to endothelial cells
injured by balloon catheters, stents, and endografts. The
rapidity with which endothelial cells can alter their pheno-
type in response to these environmental stressors listed
supports the notion that translational control mechanisms
play a significant role in regulating their function.
The response of endothelial cells to external stimuli
may occur within a broad timeframe, ranging from seconds
to days. Second-to-second responses generally involve
phosphorylation or dephosphorylation modifications of
proteins. Transcriptional control mechanisms may require
many hours or even days. Translational control responses
tend to occur in a matter of minutes to hours, providing the
cell with the opportunity to mount a phenotypic response
to an environmental challenge in an intermediate time
Table. Types of transcriptional and translational control a
Category Desc
Positive redistribution Shift of mRNA from monosom
mRNA abundance
Negative redistribution Shift of mRNA from polysome
mRNA abundance
Co-ordinate activation Shift of mRNA from monosom
to increased total mRNA abu
Co-ordinate repression Shift of mRNA from polysome
to decreased total mRNA abu
Paradoxical activation Shift of mRNA from monosom
in overall mRNA abundance
Paradoxical repression Shift of mRNA from polysome
in overall mRNA abundance
Obligatory upregulation Increased mRNA in both mono
overall increase in mRNA abu
Obligatory downregulation Decreased mRNA in both mon
overall reduction in mRNA a
No regulation No change in mRNA in monos
change in mRNA abundance
mRNA, Messenger RNA.frame (immediacy). Fluid shear stress is a particularly rele-vant environmental stimulus to endothelial cells with well-
known effects on endothelial phosphorylation events and
transcription.21 Our group has shown that fluid shear
stress also influences translational activity in vascular
endothelium.22,23
The mammalian target of rapamycin (mTOR) pathway
is a ubiquitous signaling system that regulates translation in
many cell types.24 The mTOR is a protein kinase that
directs phosphorylation of related protein kinases including
S6K1 (S6 kinase 1, previously known as P70/P85 S6
kinase).25 Activation of the mTOR pathway is crucial to the
initiation of protein synthesis in many circumstances. Rapa-
mycin (or sirolimus) is a peptide isolated from the bacteria
Streptomyces hygroscopicus. It is an important adjunct in the
study of translational control because it directly inhibits
mTOR activity. Rapamycin also has clinical applications as
an immunosuppressant and an inhibitor of cell growth
when eluted from specialized vascular stents.
Fluid flow activates the mTOR pathway in endothelial
cell and results in activation of S6K1, which facilitates 40S
ribosomal recruitment to specific mRNAs (initiation).23,26
In addition, fluid flow induces a rapid increase in the
synthesis of Bcl-3, a transcription factor that is a member of
the nuclear factor- B (NF-B) family of transcription
regulators. A key finding in these studies was that rapamy-
cin effectively blocked both the activation of S6K1 and the
synthesis of Bcl-3, but transcriptional inhibition with acti-
nomycin did not.23
Additional studies have demonstrated that the transla-
tion of E-selectin is modulated by shear stress.27 E-selectin,
a cell surface molecule inducibly expressed by endothelial
cells, is critical in leukocyte adhesion and overall endothelial
cell activation. Expression of E-selectin protein by endothe-
lial cells was induced using the traditional inflammatory
agonist tumor necrosis factor- (TNF-). Exposure to
dicted by translation state array analysis
n Translation Transcription
olysome; no change in total Increased Static
nosome; no change in total Decreased Static
olysome out of proportion
ce
Increased Increased
nosome out of proportion
ce
Decreased Decreased
olysome despite a reduction Increased Decreased
nosome despite a reduction Decreased Increased
and polysome paralleling
ce
Static Increased
and polysome paralleling
ance
Static Decreased
or polysomes; no overall Static Statics pre
riptio
e to p
to mo
e to p
ndan
to mo
ndan
e to p
to mo
some
ndan
osme
bund
omesfluid flow attenuated the expression of E-selectin in the
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to fluid flow. Fluid flow did not reduce overall E-selectin
mRNA levels but did reduce the amount of E-selectin
mRNA associated with polysomes, implying the existence
of a regulatory step that specifically regulated access of the
mRNA to the protein synthesis machinery, a form of trans-
lational control. Of interest was that neither rapamycin nor
nitric oxide synthase inhibitors eliminated the modulatory
effect of flow on E-selectin expression.23,27
This series of discoveries illustrates the concept that
endothelial cells can rapidly alter protein synthesis by dis-
crete translational control mechanisms independently of
transcription. These observations also emphasize the im-
portance of translational control in endothelial cells be-
cause of the existence of multiple regulatory pathways,
some of which are independent of the mTOR system and
the classic flow-dependent nitric oxide–signaling pathway.
Recently, translational control mechanisms have been
identified in other important cellular components in the
vascular system. Platelets, leukocytes, and vascular smooth
muscle cells all exhibit some degree of translational con-
trol.28-30 Platelets are intriguing cells for the study of
translational control because they are anucleate and lack
DNA. Despite this fact, thrombin stimulates platelet syn-
thesis of a number of proteins from pre-existing mRNA
stores derived from the parent megakaryocyte.31 In partic-
ular, platelet expression of the transcription factor Bcl-3 is
induced by thrombin activation. This was a confusing
finding initially because platelets would appear to have no
use for a transcription factor. Subsequent studies revealed
Bcl-3 to have activities apart from transcriptional regula-
tion, including participation in platelet-mediated clot re-
traction.32 Expression of Bcl-3 protein is diminished by
the translational inhibitor rapamycin, demonstrating that
platelets regulate protein synthesis through signal-
dependent activation of translation despite a lack of tran-
scriptional activity.
CONCLUSIONS
Regulation of gene expression is a complex process, and
although a great deal of work has been done on transcrip-
tional regulation in vascular biology, there are many other
factors that determine whether or not a gene ultimately
produces a functional protein that can alter cellular pheno-
type and function. Translational control mechanisms rep-
resent one manner in which cells can regulate gene expres-
sion, and although research efforts have increased in this
field, it remains vastly understudied. Translation is a com-
plex process involving interactions between outside signals,
cellular machinery, enzymes, and genetic material. Manip-
ulation of these interactions can drastically alter cellular
function, even in the absence of transcriptional changes.
With the realization that translational control is separately
targeted by extracellular signals, the classic notion of se-
quential control of gene expression shown in Fig 1 has been
refined to reflect the complex and simultaneous nature of
parallel signal input for both transcriptional and transla-
tional regulation shown in Fig 5.Endothelial cells are an intriguing model for studying
translational control mechanisms because they must re-
spond rapidly to changes in blood flow, chemical signals,
and other forms of stimulation such as mechanical trauma.
Translational control is a particularly useful type of regula-
tion that allows endothelial cells to respond to signals
relatively rapidly compared with the time required for a
transcriptional response. Continued investigation into
translational control mechanisms in endothelial cells may
provide important insights into their pathogenic responses
to stimuli and novel strategies for modulating their func-
tion. Techniques like TSAA offer an efficient means for
screening large numbers of candidate genes for evidence of
translational control, with the caveat that verification and
functional assays will still be necessary to place the results in
proper biologic perspective.
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